BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1315230)

  • 1. Cytomegalovirus antibody detection in blood donors and mothers of very low birth weight neonates by using three serologic methods.
    Eisenfeld L; McLaughlin JC; Mayo D; Klevjer-Anderson P; Silver H; Krause P; Anderson J; Herson V; Savidakis J; Lazar AM
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2):125-8. PubMed ID: 1315230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High perinatal seroprevalence of cytomegalovirus in northern Taiwan.
    Chen MH; Chen PC; Jeng SF; Hsieh CJ; Su FC; Liao HF; Su YN; Lin SJ; Hsieh WS
    J Paediatr Child Health; 2008 Apr; 44(4):166-9. PubMed ID: 17854407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of IgM antibodies against cytomegalovirus: comparison of two radioimmunoassays, enzyme-linked immunosorbent assay and immunofluorescent antibody test.
    Kangro HO; Booth JC; Bakir TM; Tryhorn Y; Sutherland S
    J Med Virol; 1984; 14(1):73-80. PubMed ID: 6086832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latex agglutination and enzyme-linked immunosorbent assays for cytomegalovirus serologic screening of transplant donors and recipients.
    Chou SW; Scott KM
    J Clin Microbiol; 1988 Oct; 26(10):2116-9. PubMed ID: 2846638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CMV screening with the latex agglutination test in blood donors. Comparison between EIA and latex agglutination].
    Müller R; Milbradt H
    Beitr Infusionsther; 1990; 26():43-5. PubMed ID: 1703892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients?].
    Mutlu B; Günlemez A; Türker G; Gökalp AS; Willke A
    Mikrobiyol Bul; 2008 Apr; 42(2):337-41. PubMed ID: 18697432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus Infection among Pregnant Women in Beijing: Seroepidemiological Survey and Intrauterine Transmissions.
    Jin Q; Su J; Wu S
    J Microbiol Biotechnol; 2017 May; 27(5):1005-1009. PubMed ID: 28285497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and gB genotyping of CMV in Mexican preterm infants in the context of maternal seropositivity.
    Arellano-Galindo J; Villanueva-García D; Cruz-Ramirez JL; Yalaupari-Mejìa JP; Uribe-Gutiérrez G; Velazquez-Guadarrama N; Nava-Frias M; Munoz-Hernández O; Mejía-Arangure JM
    J Infect Dev Ctries; 2014 Jun; 8(6):758-67. PubMed ID: 24916875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal and neonatal prevalence of toxoplasma and cytomegalovirus (CMV) antibodies and hepatitis-B antigens in an Egyptian rural area.
    el-Nawawy A; Soliman AT; el Azzouni O; Amer el-S ; Karim MA; Demian S; el Sayed M
    J Trop Pediatr; 1996 Jun; 42(3):154-7. PubMed ID: 8699582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal and congenital cytomegalovirus infections in a population-based pregnancy cohort study.
    Barlinn R; Dudman SG; Trogstad L; Gibory M; Muller F; Magnus P; Rollag H
    APMIS; 2018 Dec; 126(12):899-906. PubMed ID: 30378168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of cytomegalovirus infections during pregnancy and infancy. A prospective study.
    Leinikki P; Granström ML; Santavuori P; Pettay O
    Scand J Infect Dis; 1978; 10(3):165-71. PubMed ID: 213828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity of serologic tests for the detection of antibody specific to cytomegalovirus. II. Latex agglutination and enzyme-linked immunosorbent assay.
    LaRocco M; Mortenson J; Davis BG; Moore DG
    Am J Clin Pathol; 1986 Sep; 86(3):354-6. PubMed ID: 3019123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus infections in neonates acquired by blood transfusions.
    Adler SP; Chandrika T; Lawrence L; Baggett J
    Pediatr Infect Dis; 1983; 2(2):114-8. PubMed ID: 6304663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of cytomegalovirus antibody with latex agglutination.
    Adler SP; McVoy M; Biro VG; Britt WJ; Hider P; Marshall D
    J Clin Microbiol; 1985 Jul; 22(1):68-70. PubMed ID: 2991330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence, transmission, and associated factors of specific antibodies against cytomegalovirus among pregnant women and their infants in a regional study.
    Erfanianahmadpoor M; Nasiri R; Vakili R; Hassannia T
    Saudi Med J; 2014 Apr; 35(4):360-4. PubMed ID: 24749132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the indirect and IgM-capture anti-human cytomegalovirus IgM ELISA methods as confirmed by cytomegalovirus IgG avidity.
    Ikuta K; Koshizuka T; Kanno R; Inoue N; Kubo T; Koyano S; Suzutani T
    Microbiol Immunol; 2019 May; 63(5):172-178. PubMed ID: 31012489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of blood donors for cytomegalovirus (CMV) antibodies: an evaluation of different tests.
    Grillner L
    J Virol Methods; 1987 Aug; 17(1-2):133-9. PubMed ID: 2822749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of cytomegalovirus antibody in Thai-northeastern blood donors.
    Urwijitaroon Y; Teawpatanataworn S; Kitjareontarm A
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():180-2. PubMed ID: 7886568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cytomegalovirus (CMV) antibody screening tests for blood donors.
    Sererat MN; Schifano JV; Lau P; Beikert E; Bhumbra NA; Nankervis GA
    Am J Clin Pathol; 1986 Oct; 86(4):523-6. PubMed ID: 3020963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PREVALENCE AND ASSOCIATED CHARACTERISTICS OF CYTOMEGALOVIRUS (CMV) IMMUNOGLOBULIN ANTIBODIES AMONG BLOOD DONORS AT A UNIVERSITY TEACHING HOSPITAL IN NIGERIA.
    Bolarinwa RA; Donbraye E; Ademosu AA; Salawu L
    East Afr Med J; 2014 Nov; 91(11):385-90. PubMed ID: 26866086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.